NL-OMON35380已完成不适用
Muticentre study to investigate the efficacy of scalp cooling for the prevention of Myocet/cyclofosfamide-induced alopecia in patients with metastatic breast cancer. MyCap study - MyCap
Stichting DIADOC0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Female breast cancer patients, treated with Myocet and cyclophosphamide containing chemotherapy.
- •* Life expectancy * 12 weeks.
- •* ECOG performance scale * 2.
- •* Age 18 years and above.
排除标准
- •* Allopecia prior to start of the study.
- •* Simultaneously or shortly after study start: planned skull irradiation (if allopecia is expected).
- •* Severely disturbed liver enzymes (see protocol for details).
- •* Hair extensions
研究者
相似试验
已完成
不适用
Investigating the effect and safety of the Satisphere™ insert in overweight patientsObesityISRCTN81340421Endosphere Inc (USA)60
进行中（未招募）
不适用
A study conducted at several study sites with a human growth hormone in a liquid form and a concentration of 3.3. mg/mL that is produced by using genetic engineering techniques, to find out more about how efficacious it works and how safe its use is in pre-pubertal children of small stature who’s bodies do not produce sufficient amounts of own growth hormone.Small stature secondary to growth hormone insufficiency deficiencyEUCTR2015-002802-34-Outside-EU/EEASandoz SAS100
进行中（未招募）
不适用
A Multicenter Study Evaluating the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More Headache Days per 4-Week Period in a 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed by a 32-Week Open-Label Extension PhaseEUCTR2005-004637-17-DEALLERGAN LTD650
进行中（未招募）
1 期
A Multicenter Study Evaluating the Efficacy and Safety of BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex as Headache Prophylaxis in Migraine Patients with 15 or More Headache Days per 4-Week Period in a 24-Week, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase Followed by a 32-Week Open-Label Extension PhaseEUCTR2005-004637-17-GBALLERGAN LTD650
进行中（未招募）
不适用
Multicenter clinical study on the efficacy and safety with extensive and repeated injections of cultured (human) autologous hair follicle dermal sheath cup cells on male and female pattern hair lossJPRN-jRCTb032200148Harada Kazutoshi36